*ST榕泰(600589) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥90,205,805.26, representing a decrease of 54.57% compared to the same period last year[4]. - The net profit attributable to shareholders was -¥41,403,036.08, an increase of 204.24% year-on-year[4]. - The net profit for Q1 2023 was -41,347,945.73 RMB, compared to -13,609,919.97 RMB in Q1 2022, indicating a significant decline in profitability[20]. - The total comprehensive income for Q1 2023 was -41,347,945.73 RMB, compared to -13,609,919.97 RMB in Q1 2022, showing a significant increase in losses[21]. - The total operating profit for Q1 2023 was -41,434,064.84 RMB, compared to -12,239,515.90 RMB in Q1 2022, indicating a substantial increase in operating losses[20]. Cash Flow and Liquidity - The net cash flow from operating activities was -¥15,434,404.64, reflecting a decrease of 35.98% compared to the previous year[4]. - The cash flow from operating activities showed a net outflow of -15,434,404.64 RMB, compared to -11,350,808.40 RMB in Q1 2022, indicating worsening cash flow conditions[23]. - Cash and cash equivalents decreased to CNY 130,628,911.18 as of March 31, 2023, from CNY 152,836,646.14 at the end of 2022, representing a decline of 14.5%[15]. - The cash and cash equivalents at the end of Q1 2023 were 127,726,543.62 RMB, down from 148,991,302.09 RMB at the beginning of the quarter, indicating a decrease of approximately 14.2%[23]. - The cash outflow from operating activities totaled 88,224,229.12 RMB, down from 200,743,004.28 RMB in the previous year, reflecting a decrease of approximately 56.0%[22]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,110,688,346.02, showing a slight increase of 0.09% from the end of the previous year[5]. - Total assets as of March 31, 2023, were CNY 1,110,688,346.02, slightly up from CNY 1,109,663,305.11 at the end of 2022[18]. - Total liabilities increased to CNY 1,821,783,140.72 from CNY 1,779,410,154.08, marking an increase of 2.4%[17]. - The equity attributable to shareholders was -¥714,141,919.97, which is a decrease of 6.15% compared to the end of the previous year[5]. Shareholder Information - The company had a total of 28,946 common shareholders at the end of the reporting period[9]. Earnings and Performance Metrics - The basic and diluted earnings per share were both -¥0.059, indicating a year-on-year increase of 209.52%[4]. - The basic and diluted earnings per share for Q1 2023 were both -0.059 RMB, compared to -0.019 RMB in Q1 2022, reflecting a deterioration in earnings performance[21]. - The weighted average return on net assets was 5.97%, an increase of 23.40% compared to the previous year[4]. Operational Challenges - The significant decline in operating revenue was primarily due to the shutdown of the chemical business[7]. - The company is actively working on debt restructuring and asset disposal to mitigate the impact of the non-standard audit opinion received for 2022[14]. - The company has implemented measures to enhance management capabilities and strengthen cost control[14]. - The company continues to face risks related to stock delisting warnings as per the Shanghai Stock Exchange regulations[12]. Investment Performance - The company reported an investment loss of 106,998.54 RMB, compared to a gain of 22,847.50 RMB in the previous year, highlighting a negative shift in investment performance[20]. - The company reported non-recurring gains and losses totaling ¥537,453.84 for the period[7]. Revenue and Costs - Total revenue for Q1 2023 was CNY 90,205,805.26, a decrease of 54.5% compared to CNY 198,561,933.01 in Q1 2022[19]. - Operating costs for Q1 2023 were CNY 77,393,176.42, down from CNY 179,470,958.18 in Q1 2022, reflecting a significant reduction in expenses[19]. - The total revenue from operating activities was 72,789,824.48 RMB, down from 189,392,195.88 RMB in the same period last year, reflecting a decrease of approximately 61.5%[22].